Artificial intelligence and high-resolution anoscopy: automatic identification of anal squamous cell carcinoma precursors using a convolutional neural network

Autor: M. M. Saraiva, L. Spindler, N. Fathallah, H. Beaussier, C. Mamma, M. Quesnée, T. Ribeiro, J. Afonso, M. Carvalho, R. Moura, P. Andrade, H. Cardoso, J. Adam, J. Ferreira, G. Macedo, V. de Parades

Publikováno v: Techniques in Coloproctology. 26:893-900

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4bfd466a84aca23252bb14d7753cf99
https://doi.org/10.1007/s10151-022-02684-z

The comeback of hemorrhoidal sclerotherapy?

Autor: V. de Parades, M. Aubert, N. Fathallah, A. A. Alam, L. Spindler, P. Benfredj

Publikováno v: Techniques in Coloproctology. 26:599-601

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f381e508a0cb254eba3b0edbf47b112
https://doi.org/10.1007/s10151-022-02640-x

Epidemiology of symptomatic infective anoproctitis in a population of men having sex with men (MSM)

Autor: J. Lourtet-Hascoet, L. Mine, L. Spindler, B. Pilmis, M. Aubert, A. EL Mituialy, V. Vieillefond, V. de Parades, A. Le Monnier

Publikováno v: Infection
Infection, 2022, 50 (4), pp.933-940. ⟨10.1007/s15010-022-01766-2⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4438fa2e147e0a727b9e5e2ae67c7c3
https://hal.inrae.fr/hal-04145014

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

Autor: S. Rao, G. Anandappa, J. Capdevila, L. Dahan, L. Evesque, S. Kim, M.P. Saunders, D.C. Gilbert, L.H. Jensen, E. Samalin, K.-L. Spindler, S. Tamberi, A. Demols, M.G. Guren, D. Arnold, M. Fakih, T. Kayyal, M. Cornfeld, C. Tian, M. Catlett, M. Smith, J.-P. Spano

Publikováno v: Scientia
Rao, S, Anandappa, G, Capdevila, J, Dahan, L, Evesque, L, Kim, S, Saunders, M P, Gilbert, D C, Jensen, L H, Samalin, E, Spindler, K L, Tamberi, S, Demols, A, Guren, M G, Arnold, D, Fakih, M, Kayyal, T, Cornfeld, M, Tian, C, Catlett, M, Smith, M & Spano, J P 2022, ' A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) ', ESMO Open, vol. 7, no. 4, 100529 . https://doi.org/10.1016/j.esmoop.2022.100529

PD-L1 inhibitor; Anal cancer; Retifanlimab Inhibidor de PD-L1; Cáncer anal; Retifanlimab Inhibidor de PD-L1; Càncer anal; Retifanlimab Background Locally advanced or metastatic squamous carcinoma of the anal canal (SCAC) has poor prognosis followin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187fd16c9a4b6f5c22835443c168b40a
https://pubmed.ncbi.nlm.nih.gov/35816951